[Lipodystrophy syndrome associated with human immunodeficiency virus infection (II). Clinical and therapeutic issues]

Rev Clin Esp. 2002 Apr;202(4):217-20. doi: 10.1016/s0014-2565(02)71031-x.
[Article in Spanish]
No abstract available

MeSH terms

  • Acidosis / prevention & control
  • Acquired Immunodeficiency Syndrome / complications*
  • Acquired Immunodeficiency Syndrome / drug therapy*
  • Antioxidants / therapeutic use
  • Antiretroviral Therapy, Highly Active / methods*
  • Humans
  • Hypercholesterolemia / epidemiology
  • Lipodystrophy* / drug therapy
  • Lipodystrophy* / etiology
  • Lipodystrophy* / physiopathology

Substances

  • Antioxidants